Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SOLARA ACTIVE PHARMA SCIENCES LIMITED Call Transcript 2025

Oct 30, 2025

61842_rns_2025-10-30_507e87ef-c419-4b31-986b-1571403714ae.pdf

Call Transcript

Open in viewer

Opens in your device viewer

Corporate Office: Solara Active Pharma Sciences Limited TICEL Bio Park, 6th Floor, Module No. 601, 602, 603, Phase II – CSIR Road, Taramani, Chennai, Tamil Nadu – 600113. Tel: +91 44 47406700 Fax: +91 44 47406190 E-mail: [email protected] Website: www.solara.co.in

==> picture [180 x 70] intentionally omitted <==

October 30, 2025

The BSE LimitedPhiroze Jeejeebhoy TowersDalal Street, Mumbai – 400 001 The National Stock Exchange of India LimitedExchange Plaza, C-1, Block G, Bandra-KurlaComplex, Bandra (E), Mumbai – 400 051

Scrip Code: 541540, 890202 Symbol: SOLARA, SOLARAPP1

Dear Sir / Madam,

Subject: Intimation of Analysts / Investors Conference Call

This is to inform you that the Company has scheduled a conference call with analysts/ investors on Wednesday, November 05, 2025, at 03:30 pm IST to discuss Company’s unaudited financial results for the quarter and half year ended September 30, 2025.

Earnings Call details are enclosed for ready reference.

Further, kindly note that the above information will also be available on the website of the Company i.e., www.solara.co.in.

This is for your information and records.

Thanking you, Yours faithfully,

For Solara Active Pharma Sciences Limited

POOJA JAYA Digitally signed by POOJA JAYA KUMAR KUMAR Date: 2025.10.30 21:05:26 +05'30' Pooja Jaya Kumar Company Secretary & Compliance Officer Membership No: A57415

Solara Active Pharma Sciences Limited - CIN: L24230MH2017PLC291636 Registered Office: 9[th ] Floor, ‘Cyber One’, Unit No. 902, Plot No. 4 & 6, Sector 30A, Vashi, Navi Mumbai - 400 703 / Tel: +91-22-2517 2163

Solara Conference Call Wednesday, 5[th] November 2025, 3:30 pm IST

==> picture [208 x 240] intentionally omitted <==

. Pure play APIs SOLARA ACTIVE PHARMA SCIENCES | Q2FY26

Arun Kumar, Founder & Non-Executive Director Sandeep Rao, MD & CEO Sarat Kumar, CFO

Dial in Details: For Solara’s conference call, Wednesday 5[th] November 2025, 3:30 pm IST Universal Access +91 22 6280 1346 +91 22 7115 8247 Diamond Pass Click here (for early registration)

1